SavedAdd your journal

Journals / ANKEM Dergisi / 2008 / Cilt: 22 - Sayı: 3

Quinolone resistance in neisseria gonorrhoeae: Istanbul Medical Faculty 2002-200

Neisseria gonorrhoeae’de kinolon direnci: İstanbul Tıp Fakültesi 2002-2006

Ahmet BALIKÇI
Derya AYDIN
Pages
145–147
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Due to their high resistance rates, quinolones, penicillin and tetracycline should not be used in empirical treatment of gonococcal infections.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Quinolone-resistant Neisseria gonorrhoeae (QRNg) strains isolated from male patients with urethritis in 2002-2006 were reported.
📊
Key Findings & Data:In this period the mean percentage of QRNg was detected as 33 % (18/54 isolates) and, penicillin- and tetracycline-resistant strains were 62 % and 61 %, respectively.
💡
Conclusion & Impact:Due to their high resistance rates, quinolones, penicillin and tetracycline should not be used in empirical treatment of gonococcal infections.
🔬Design:Research Article
📍Scope:2002-2006 Verileri
⚙️Variables:İlaç direnci · mikrobiyal · Kinolonlar

Abstract

Quinolone-resistant Neisseria gonorrhoeae (QRNg) strains isolated from male patients with urethritis in 2002-2006 were reported. In this period the mean percentage of QRNg was detected as 33 % (18/54 isolates) and, penicillin- and tetracycline-resistant strains were 62 % and 61 %, respectively. No resistant strain was detected for ceftriaxone, cefoxitin and cefuroxime. Due to their high resistance rates, quinolones, penicillin and tetracycline should not be used in empirical treatment of gonococcal infections.

Özet

Üretritli erkek hastalardan 2002-2006 yıllarında izole edilen kinolon dirençli Neisseria gonorrhoeae (KDNg) suşları bildirilmiştir. Bu süre için ortalama KDNg oranı % 33 (18/54 izolat), penisilin ve tetrasikline dirençli suş oranları sırasıyla % 62 ve % 61 olarak saptanmıştır. Seftriakson, sefoksitin ve sefuroksime dirençli suş saptanmamıştır. Yüksek direnç oranları nedeniyle, kinolonlar, penisilin ve tetrasiklin gonokok infeksiyonlarının ampirik tedavisinde kullanılmamalıdır.

🔖

Cite This Article

BALIKÇI, A., AYDIN, D. (2008). Quinolone resistance in neisseria gonorrhoeae: Istanbul Medical Faculty 2002-200. ANKEM Dergisi, Cilt: 22 - Sayı: 3, 145–147. https://ajindex.com/articles/193170

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Aydın D, Küçükbasmacı Ö, Gönüllü N, Aktaş Z: Susceptibilities of Neisseria gonorrhoeae and Ureaplasma urealyticum isolates from male patients with urethritis to several antibiotics including telithromycin, Chemotherapy 2005;51(2-3):89-92
  2. Aydın MD: Neisseria gonorrhoeae suşlarında antibiyotik direnci ve betalaktamaz üretimi: 1996-2001, ANKEM Derg 2002;16(4):481-5
  3. Badescu AC, Petrescu Z, Enache A, Buiuc D: Antimicrobial resistance in Neisseria gonorrhoeae in North-East Romania, Rev Med Chir Soc Med Nat Iasi 2007;111(2):512-5
  4. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement, CLSI Document M100-S16, Wayne, PA (2006)
  5. Fenton KA, Lowndes CM: Recent trends in the epidemiology of sexually transmitted infections in the European Union, Sex Transm Infect 2004;80(4):255-63
  6. Kubanova A, Frigo N, Kubanov A et al: National surveillance of antimicrobial susceptibility in Neisseria gonorrhoeae in 2005-2006 and recommendations of first-line antimicrobials for gonorrhoea treatment in Russia, Sex Transm Infect 2008 Feb 6 (http://sti.bmj.com/cgi/content/abstract/ sti.2007.029033v1)
  7. Le Lin B, Pastore R, Liassine N, Aramburu C, Sudre P: A new sexually transmitted infection (STI) in Geneva? Ciprofloxacin-resistant Neisseria gonorrhoeae, 2002-2005, Swiss Med Wkly 2008;138(15-16):243-6
  8. Stathi M, Flemetakis A, MiriagouVivi et al: Antimicrobial susceptibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004, J Antimicrob Chemother 2006;57(4):775-9.